About the Radioligand Therapy Readiness Hub

The Radioligand Therapy Readiness Hub is a collection of examples highlighting different ways of improving the integration of radioligand therapy into cancer care, and boosting readiness for the approach in the future. Learn more about why readiness for radioligand therapy is important and how shared learnings can help achieve readiness for the therapy here.

Effective integration of radioligand therapy into care requires careful planning. Potential barriers to integration can come from any area of a health system: governance, regulation and reimbursement, identified need, service provision and health information.

We are still collecting examples for the hub. If you have been involved in an activity that has addressed barriers to integrating radioligand therapy, please share your experiences with us.

To find out how examples for the hub are identified, please click the button below to read the full methodology.

Filter by

Filter

Condition

Location

Focus

An international guide on how to set up a theranostics centre
An international guide on how to set up a theranostics centre
The European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging and the International Atomic Energy Agency have created a joint guide to help people looking to establish theranostics centres.
Read More
Improving knowledge and awareness of radioligand therapy among nurses
Improving knowledge and awareness of radioligand therapy among nurses
Training courses in Poland have been created to ensure nurses understand radioligand therapy, so that they can effectively support delivery and communicate with patients.
Read More
Australian round-table event raises awareness of radioligand therapy
Australian round-table event raises awareness of radioligand therapy
NeuroEndocrine Cancer Australia brought together a multi-sectoral group of experts to discuss the future of precision oncology in nuclear medicine, including radioligand therapy.
Read More
A framework for patient-centred pathways for radioligand therapy
A framework for patient-centred pathways for radioligand therapy
ASTRO has developed a framework for radioligand therapy patient-centred care pathways which outlines what is needed to ensure safe, high-quality care for people with cancer.
Read More
Joint ESMO–EANM course: improving awareness and collaboration within the radioligand therapy team
Joint ESMO–EANM course: improving awareness and collaboration within the radioligand therapy team
ESMO and EANM have developed an advanced course on diagnostic and therapeutic applications of nuclear medicine in oncology.
Read More
Get in touch

For more information about this project, contact us at info@radioligandtherapy.com

We’re on Twitter! Follow @radioligand for updates on this project and other exciting developments in targeted cancer care.